TG Therapeutics' stock rose 15% since my November buy recommendation, driven by Briumvi's strong performance and strategic ...

Studies conducted in mice have shown that the COVID-19 vaccine being developed by researchers at the University of São ...

Cybin (NYSE American: CYBN) (NEO: CYBN) , a neuropsychiatry platform company, announced its first strategic partnership agreement (“SPA”) with Segal Trials as part of its multinational pivotal Phase 3 ...

Analyst Daina Graybosch of Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research Report), reducing the price target ...

“Most vaccines are based on attenuated or inactivated viruses, but our next-generation strategy enables us to prioritize not just safety and efficacy but also plasticity in the formulation so that the ...

Regeneron shares have been in a bearish trend since August, losing over one third of their value. Read why I am initiating ...

New research published in the New England Journal of Medicine has shown a single dose of the influenza vaccine is sufficient ...

Ukrainian President Volodymyr Zelenskyy will personally attend the World Economic Forum in Davos, held from January 20-24. US ...

Iconovo deal aims to identify the deal product properties concerning particle size, stability, and device compatibility.

A central focus of the discussions was the formulation of a comprehensive roadmap for practical cooperation across a wide ...